SOAT1 and pemphigus foliaceus: (16) Tacrolimus: In the animal model of PF, tacrolimus inhibits signaling of JAK/STAT pathways and suppresses M2 polarization and M2-induced myofibroblast activation, thereby alleviating PF progression [108].